Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer

Oncotarget. 2016 May 3;7(18):25315-27. doi: 10.18632/oncotarget.8287.

Abstract

Multi-drug resistance (MDR) remains a great obstacle to effective chemotherapy for gastric cancer. A number of secreted glycoproteins have been reported to be involved in the development of MDR in gastric cancer. However, whether glycosylation of secreted glycoproteins changes during MDR of gastric cancer is unclear. Our present work manifested that N-glycosites and site-specific glycoforms of secreted proteins in drug-resistant cell lines were distinctly different from those in the parental cell line for the first time. Further characterization highlighted the significance of some aberrantly glycosylated secretory proteins in MDR, suggesting that manipulating the glycosylation of specific glycoproteins could be a potential target for overcoming multi-drug resistance in gastric cancer.

Keywords: chemoresistance; gastric cancer; glycoprotein; secretome analysis; site-specific glycosylation.

MeSH terms

  • Cell Line, Tumor
  • Drug Resistance, Multiple / physiology*
  • Drug Resistance, Neoplasm / physiology*
  • Glycoproteins / metabolism
  • Glycosylation*
  • Humans
  • Proteomics
  • Stomach Neoplasms / metabolism*

Substances

  • Glycoproteins